Yuan Y - Search Results

1

Ultrasound-Activated PROTAC Prodrugs Overcome Immunosuppression to Actuate Efficient Deep-Tissue Sono-Immunotherapy in Orthotopic Pancreatic Tumor Mouse Models.

Liu Y, Wang H, Ding M, Yao W, Wang K, Ullah I, Bulatov E, Yuan Y. Liu Y, et al. Among authors: yuan y. Nano Lett. 2024 Jul 17;24(28):8741-8751. doi: 10.1021/acs.nanolett.4c02287. Epub 2024 Jul 2. Nano Lett. 2024. PMID: 38953486

2

Size-Switchable Nanoparticles with Self-Destructive and Tumor Penetration Characteristics for Site-Specific Phototherapy of Cancer.

Wang K, Tu Y, Yao W, Zong Q, Xiao X, Yang RM, Jiang XQ, Yuan Y. Wang K, et al. Among authors: yuan y. ACS Appl Mater Interfaces. 2020 Feb 12;12(6):6933-6943. doi: 10.1021/acsami.9b21525. Epub 2020 Feb 3. ACS Appl Mater Interfaces. 2020. PMID: 31951372

3

A General Strategy for Macrotheranostic Prodrug Activation: Synergy between the Acidic Tumor Microenvironment and Bioorthogonal Chemistry.

Dong Y, Tu Y, Wang K, Xu C, Yuan Y, Wang J. Dong Y, et al. Among authors: yuan y. Angew Chem Int Ed Engl. 2020 Apr 27;59(18):7168-7172. doi: 10.1002/anie.201913522. Epub 2020 Mar 6. Angew Chem Int Ed Engl. 2020. PMID: 32003112

4

Dual-Drug Backboned Polyprodrug with a Predefined Drug Combination for Synergistic Chemotherapy.

Yu F, Tu Y, Luo S, Xiao X, Yao W, Jiang M, Jiang X, Yang R, Yuan Y. Yu F, et al. Among authors: yuan y. Nano Lett. 2021 Mar 10;21(5):2216-2223. doi: 10.1021/acs.nanolett.0c05028. Epub 2021 Feb 26. Nano Lett. 2021. PMID: 33635657

5

Bioorthogonal Pretargeting Strategy for Anchoring Activatable Photosensitizers on Plasma Membranes for Effective Photodynamic Therapy.

Wei R, Dong Y, Tu Y, Luo S, Pang X, Zhang W, Yao W, Tang W, Yang H, Wei X, Jiang X, Yuan Y, Yang R. Wei R, et al. Among authors: yuan y. ACS Appl Mater Interfaces. 2021 Mar 31;13(12):14004-14014. doi: 10.1021/acsami.1c01259. Epub 2021 Mar 17. ACS Appl Mater Interfaces. 2021. PMID: 33728894

6

An NIR-Fluorophore-Based Theranostic for Selective Initiation of Tumor Pyroptosis-Induced Immunotherapy.

Wang K, Xiao X, Jiang M, Li J, Zhou J, Yuan Y. Wang K, et al. Among authors: yuan y. Small. 2021 Sep;17(36):e2102610. doi: 10.1002/smll.202102610. Epub 2021 Jul 29. Small. 2021. PMID: 34323375

7

Theranostic Heterodimeric Prodrug with Dual-Channel Fluorescence Turn-On and Dual-Prodrug Activation for Synergistic Cancer Therapy.

Jiang M, Wang K, Xiao X, Zong Q, Zheng R, Yuan Y. Jiang M, et al. Among authors: yuan y. Adv Healthc Mater. 2021 Nov;10(21):e2101144. doi: 10.1002/adhm.202101144. Epub 2021 Aug 28. Adv Healthc Mater. 2021. PMID: 34453773

8

Tumor-Acidity and Bioorthogonal Chemistry-Mediated On-Site Size Transformation Clustered Nanosystem to Overcome Hypoxic Resistance and Enhance Chemoimmunotherapy.

Wang K, Jiang M, Zhou J, Liu Y, Zong Q, Yuan Y. Wang K, et al. Among authors: yuan y. ACS Nano. 2022 Jan 25;16(1):721-735. doi: 10.1021/acsnano.1c08232. Epub 2022 Jan 3. ACS Nano. 2022. PMID: 34978422

9

Self-catalyzed tumor ferroptosis based on ferrocene conjugated reactive oxygen species generation and a responsive polymer.

Li J, Zong Q, Liu Y, Xiao X, Zhou J, Zhao Z, Yuan Y. Li J, et al. Among authors: yuan y. Chem Commun (Camb). 2022 Mar 8;58(20):3294-3297. doi: 10.1039/d1cc06742g. Chem Commun (Camb). 2022. PMID: 35175251

10

Dual stimulus-triggered bioorthogonal nanosystem for spatiotemporally controlled prodrug activation and near-infrared fluorescence imaging.

Zhao Z, Zong Q, Li J, Jiang M, Wang K, Yuan Y. Zhao Z, et al. Among authors: yuan y. Chem Commun (Camb). 2023 Mar 28;59(26):3878-3881. doi: 10.1039/d3cc00177f. Chem Commun (Camb). 2023. PMID: 36916644

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

21,645 results

Search Page

Filters